JPWO2018213588A5

JPWO2018213588A5 -

Download PDF

Info

Publication number: JPWO2018213588A5
Authority: JP; Japan
Prior art keywords: equal; less; self; article; tissue
Prior art date: 2022-02-09
Legal status : Granted

Application number

JP2019563359A

Other languages

English (en)

Japanese (ja)

Other versions

JP2020520907A5 (fr

JP2020520907A (ja

JP7044805B2 (ja

Publication date

2022-02-09

2018-05-17 Application filed filed Critical

2018-05-17 Priority claimed from PCT/US2018/033204 external-priority patent/WO2018213588A1/fr

2020-07-16 Publication of JP2020520907A publication Critical patent/JP2020520907A/ja

2021-07-26 Publication of JP2020520907A5 publication Critical patent/JP2020520907A5/ja

2022-02-09 Publication of JPWO2018213588A5 publication Critical patent/JPWO2018213588A5/ja

2022-03-30 Application granted granted Critical

2022-03-30 Publication of JP7044805B2 publication Critical patent/JP7044805B2/ja

Status Active legal-status Critical Current

2038-05-17 Anticipated expiration legal-status Critical

Links

239000000463 material Substances 0.000 claims description 179
230000004962 physiological condition Effects 0.000 claims description 8
230000000284 resting Effects 0.000 claims description 4
210000001519 tissues Anatomy 0.000 description 651
NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 217
239000003814 drug Substances 0.000 description 154
239000000203 mixture Substances 0.000 description 139
210000002784 Stomach Anatomy 0.000 description 124
239000008186 active pharmaceutical agent Substances 0.000 description 120
108090001061 Insulin Proteins 0.000 description 107
102000004877 Insulin Human genes 0.000 description 107
239000007787 solid Substances 0.000 description 83
239000012530 fluid Substances 0.000 description 82
229940079593 drugs Drugs 0.000 description 69
230000002496 gastric Effects 0.000 description 66
241000282898 Sus scrofa Species 0.000 description 60
239000002775 capsule Substances 0.000 description 53
239000011248 coating agent Substances 0.000 description 52
238000000576 coating method Methods 0.000 description 52
239000003795 chemical substances by application Substances 0.000 description 50
CZMRCDWAGMRECN-UGDNZRGBSA-N D-sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 43
CZMRCDWAGMRECN-GDQSFJPYSA-N Sucrose Natural products O([C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O1)[C@@]1(CO)[C@H](O)[C@@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-GDQSFJPYSA-N 0.000 description 43
239000005720 sucrose Substances 0.000 description 43
238000011068 load Methods 0.000 description 39
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 39
229920001610 polycaprolactone Polymers 0.000 description 38
239000004632 polycaprolactone Substances 0.000 description 38
229920000642 polymer Polymers 0.000 description 38
230000035515 penetration Effects 0.000 description 37
241000282887 Suidae Species 0.000 description 36
239000011230 binding agent Substances 0.000 description 36
238000007906 compression Methods 0.000 description 36
229910001220 stainless steel Inorganic materials 0.000 description 34
239000010935 stainless steel Substances 0.000 description 34
238000004090 dissolution Methods 0.000 description 28
235000013305 food Nutrition 0.000 description 28
238000003780 insertion Methods 0.000 description 27
-1 iron-carbon Chemical compound 0.000 description 25
239000000523 sample Substances 0.000 description 25
238000009472 formulation Methods 0.000 description 24
229920001223 polyethylene glycol Polymers 0.000 description 24
230000014759 maintenance of location Effects 0.000 description 23
229910052751 metal Inorganic materials 0.000 description 23
239000002184 metal Substances 0.000 description 23
235000000346 sugar Nutrition 0.000 description 23
239000002202 Polyethylene glycol Substances 0.000 description 22
238000004519 manufacturing process Methods 0.000 description 22
230000000694 effects Effects 0.000 description 21
238000002474 experimental method Methods 0.000 description 21
239000007788 liquid Substances 0.000 description 21
239000008177 pharmaceutical agent Substances 0.000 description 21
230000005484 gravity Effects 0.000 description 20
229960005486 vaccines Drugs 0.000 description 20
238000000338 in vitro Methods 0.000 description 19
239000002585 base Substances 0.000 description 18
108010000521 Human Growth Hormone Proteins 0.000 description 17
102000002265 Human Growth Hormone Human genes 0.000 description 17
239000000854 Human Growth Hormone Substances 0.000 description 17
238000005259 measurement Methods 0.000 description 16
230000035882 stress Effects 0.000 description 16
210000001035 Gastrointestinal Tract Anatomy 0.000 description 15
238000004458 analytical method Methods 0.000 description 15
238000001574 biopsy Methods 0.000 description 15
239000000843 powder Substances 0.000 description 15
238000010586 diagram Methods 0.000 description 14
210000000813 small intestine Anatomy 0.000 description 14
210000004369 Blood Anatomy 0.000 description 13
210000004051 Gastric Juice Anatomy 0.000 description 13
241000700159 Rattus Species 0.000 description 13
239000008280 blood Substances 0.000 description 13
229920002451 polyvinyl alcohol Polymers 0.000 description 13
230000000638 stimulation Effects 0.000 description 13
210000004696 Endometrium Anatomy 0.000 description 12
210000004400 Mucous Membrane Anatomy 0.000 description 12
210000003097 Mucus Anatomy 0.000 description 12
239000000853 adhesive Substances 0.000 description 12
230000001070 adhesive Effects 0.000 description 12
238000000034 method Methods 0.000 description 12
210000003238 Esophagus Anatomy 0.000 description 11
239000004480 active ingredient Substances 0.000 description 11
238000004166 bioassay Methods 0.000 description 11
238000009826 distribution Methods 0.000 description 11
229920001971 elastomer Polymers 0.000 description 11
238000011084 recovery Methods 0.000 description 11
201000010099 disease Diseases 0.000 description 10
239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 10
229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 10
235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 10
239000007924 injection Substances 0.000 description 10
XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 10
239000003921 oil Substances 0.000 description 10
235000019198 oils Nutrition 0.000 description 10
102000004169 proteins and genes Human genes 0.000 description 10
108090000623 proteins and genes Proteins 0.000 description 10
239000000243 solution Substances 0.000 description 10
VUKAUDKDFVSVFT-UHFFFAOYSA-N 2-[6-[4,5-bis(2-hydroxypropoxy)-2-(2-hydroxypropoxymethyl)-6-methoxyoxan-3-yl]oxy-4,5-dimethoxy-2-(methoxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)-5-methoxyoxane-3,4-diol Chemical compound COC1C(OC)C(OC2C(C(O)C(OC)C(CO)O2)O)C(COC)OC1OC1C(COCC(C)O)OC(OC)C(OCC(C)O)C1OCC(C)O VUKAUDKDFVSVFT-UHFFFAOYSA-N 0.000 description 9
210000000088 Lip Anatomy 0.000 description 9
239000004372 Polyvinyl alcohol Substances 0.000 description 9
239000000919 ceramic Substances 0.000 description 9
LFQSCWFLJHTTHZ-UHFFFAOYSA-N ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
238000001802 infusion Methods 0.000 description 9
238000002347 injection Methods 0.000 description 9
238000005457 optimization Methods 0.000 description 9
239000002953 phosphate buffered saline Substances 0.000 description 9
235000018102 proteins Nutrition 0.000 description 9
239000000126 substance Substances 0.000 description 9
102000016943 Muramidase Human genes 0.000 description 8
108010014251 Muramidase Proteins 0.000 description 8
210000003205 Muscles Anatomy 0.000 description 8
238000001069 Raman spectroscopy Methods 0.000 description 8
NDVLTYZPCACLMA-UHFFFAOYSA-N Silver oxide Chemical compound [O-2].[Ag+].[Ag+] NDVLTYZPCACLMA-UHFFFAOYSA-N 0.000 description 8
210000002105 Tongue Anatomy 0.000 description 8
239000004020 conductor Substances 0.000 description 8
229910000939 field's metal Inorganic materials 0.000 description 8
239000007789 gas Substances 0.000 description 8
230000000670 limiting Effects 0.000 description 8
239000004325 lysozyme Substances 0.000 description 8
229960000274 lysozyme Drugs 0.000 description 8
235000010335 lysozyme Nutrition 0.000 description 8
210000004877 mucosa Anatomy 0.000 description 8
PXHVJJICTQNCMI-UHFFFAOYSA-N nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 8
229910052725 zinc Inorganic materials 0.000 description 8
239000011701 zinc Substances 0.000 description 8
102100005993 G6PD Human genes 0.000 description 7
210000004211 Gastric Acid Anatomy 0.000 description 7
108010018962 Glucosephosphate Dehydrogenase Proteins 0.000 description 7
229940088597 Hormone Drugs 0.000 description 7
210000003491 Skin Anatomy 0.000 description 7
230000004913 activation Effects 0.000 description 7
238000006065 biodegradation reaction Methods 0.000 description 7
230000015572 biosynthetic process Effects 0.000 description 7
238000005094 computer simulation Methods 0.000 description 7
238000005538 encapsulation Methods 0.000 description 7
238000005755 formation reaction Methods 0.000 description 7
239000005556 hormone Substances 0.000 description 7
238000001727 in vivo Methods 0.000 description 7
229920000052 poly(p-xylylene) Polymers 0.000 description 7
150000008163 sugars Chemical class 0.000 description 7
HCHKCACWOHOZIP-UHFFFAOYSA-N zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 7
235000016804 zinc Nutrition 0.000 description 7
210000003467 Cheek Anatomy 0.000 description 6
WQZGKKKJIJFFOK-GASJEMHNSA-N D-Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 6
GUBGYTABKSRVRQ-YOLKTULGSA-N Maltose Natural products O([C@@H]1[C@H](O)[C@@H](O)[C@H](O)O[C@H]1CO)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 GUBGYTABKSRVRQ-YOLKTULGSA-N 0.000 description 6
229910000831 Steel Inorganic materials 0.000 description 6
QTBSBXVTEAMEQO-UHFFFAOYSA-N acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
ODINCKMPIJJUCX-UHFFFAOYSA-N calcium monoxide Chemical compound [Ca]=O ODINCKMPIJJUCX-UHFFFAOYSA-N 0.000 description 6
230000015556 catabolic process Effects 0.000 description 6
230000004059 degradation Effects 0.000 description 6
238000006731 degradation reaction Methods 0.000 description 6
239000008103 glucose Substances 0.000 description 6
230000001965 increased Effects 0.000 description 6
230000003993 interaction Effects 0.000 description 6
230000000968 intestinal Effects 0.000 description 6
HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 6
108010045030 monoclonal antibodies Proteins 0.000 description 6
102000005614 monoclonal antibodies Human genes 0.000 description 6
239000002245 particle Substances 0.000 description 6
239000006187 pill Substances 0.000 description 6
229920000435 poly(dimethylsiloxane) Polymers 0.000 description 6
VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 6
150000003384 small molecules Chemical group 0.000 description 6
239000010959 steel Substances 0.000 description 6
150000003431 steroids Chemical class 0.000 description 6
230000004936 stimulating Effects 0.000 description 6
229910000619 316 stainless steel Inorganic materials 0.000 description 5
108010007562 Adalimumab Proteins 0.000 description 5
BLUAFEHZUWYNDE-NNWCWBAJSA-N Artemisinin Chemical compound C([C@](OO1)(C)O2)C[C@H]3[C@H](C)CC[C@@H]4[C@@]31[C@@H]2OC(=O)[C@@H]4C BLUAFEHZUWYNDE-NNWCWBAJSA-N 0.000 description 5
210000001072 Colon Anatomy 0.000 description 5
241000282412 Homo Species 0.000 description 5
229960003284 Iron Drugs 0.000 description 5
SERLAGPUMNYUCK-DCUALPFSSA-N Isomalt Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O SERLAGPUMNYUCK-DCUALPFSSA-N 0.000 description 5
LAZPBGZRMVRFKY-HNCPQSOCSA-N Levamisole hydrochloride Chemical compound Cl.C1([C@H]2CN3CCSC3=N2)=CC=CC=C1 LAZPBGZRMVRFKY-HNCPQSOCSA-N 0.000 description 5
241001465754 Metazoa Species 0.000 description 5
229940023488 Pill Drugs 0.000 description 5
239000004698 Polyethylene (PE) Substances 0.000 description 5
CXQXSVUQTKDNFP-UHFFFAOYSA-N Simethicone Chemical compound C[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C CXQXSVUQTKDNFP-UHFFFAOYSA-N 0.000 description 5
210000000587 Skeletal Muscle Fibers Anatomy 0.000 description 5
239000002253 acid Substances 0.000 description 5
229960002964 adalimumab Drugs 0.000 description 5
108090001123 antibodies Proteins 0.000 description 5
102000004965 antibodies Human genes 0.000 description 5
238000004891 communication Methods 0.000 description 5
238000009792 diffusion process Methods 0.000 description 5
239000004205 dimethyl polysiloxane Substances 0.000 description 5
235000013870 dimethyl polysiloxane Nutrition 0.000 description 5
238000006073 displacement reaction Methods 0.000 description 5
230000005611 electricity Effects 0.000 description 5
238000011156 evaluation Methods 0.000 description 5
239000011810 insulating material Substances 0.000 description 5
229910052742 iron Inorganic materials 0.000 description 5
239000000905 isomalt Substances 0.000 description 5
235000010439 isomalt Nutrition 0.000 description 5
230000004807 localization Effects 0.000 description 5
229910001000 nickel titanium Inorganic materials 0.000 description 5
108020004707 nucleic acids Proteins 0.000 description 5
150000007523 nucleic acids Chemical class 0.000 description 5
238000004987 plasma desorption mass spectroscopy Methods 0.000 description 5
229920000747 poly(lactic acid) polymer Polymers 0.000 description 5
229920000573 polyethylene Polymers 0.000 description 5
239000004626 polylactic acid Substances 0.000 description 5
230000004044 response Effects 0.000 description 5
238000007920 subcutaneous administration Methods 0.000 description 5
239000001993 wax Substances 0.000 description 5
206010002091 Anaesthesia Diseases 0.000 description 4
TZCXTZWJZNENPQ-UHFFFAOYSA-L Barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 description 4
230000036868 Blood Concentration Effects 0.000 description 4
FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 4
FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 4
210000001198 Duodenum Anatomy 0.000 description 4
UCTWMZQNUQWSLP-VIFPVBQESA-N Epinephrine Chemical compound CNC[C@H](O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-VIFPVBQESA-N 0.000 description 4
108010010803 Gelatin Proteins 0.000 description 4
210000002464 Muscle, Smooth, Vascular Anatomy 0.000 description 4
210000003254 Palate Anatomy 0.000 description 4
210000002381 Plasma Anatomy 0.000 description 4
239000004743 Polypropylene Substances 0.000 description 4
241000270666 Testudines Species 0.000 description 4
230000001133 acceleration Effects 0.000 description 4
230000037005 anaesthesia Effects 0.000 description 4
239000003430 antimalarial agent Substances 0.000 description 4
239000011324 bead Substances 0.000 description 4
230000006399 behavior Effects 0.000 description 4
229920000249 biocompatible polymer Polymers 0.000 description 4
229960000074 biopharmaceuticals Drugs 0.000 description 4
229920003013 deoxyribonucleic acid Polymers 0.000 description 4
235000015872 dietary supplement Nutrition 0.000 description 4
210000002249 digestive system Anatomy 0.000 description 4
238000003618 dip coating Methods 0.000 description 4
229960005139 epinephrine Drugs 0.000 description 4
239000003925 fat Substances 0.000 description 4
229920000159 gelatin Polymers 0.000 description 4
239000008273 gelatin Substances 0.000 description 4
235000019322 gelatine Nutrition 0.000 description 4
235000011852 gelatine desserts Nutrition 0.000 description 4
PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 4
229910052737 gold Inorganic materials 0.000 description 4
239000010931 gold Substances 0.000 description 4
238000004128 high performance liquid chromatography Methods 0.000 description 4
229910052588 hydroxylapatite Inorganic materials 0.000 description 4
238000003384 imaging method Methods 0.000 description 4
150000002739 metals Chemical class 0.000 description 4
229910052759 nickel Inorganic materials 0.000 description 4
230000000414 obstructive Effects 0.000 description 4
239000000825 pharmaceutical preparation Substances 0.000 description 4
229920001155 polypropylene Polymers 0.000 description 4
229920000036 polyvinylpyrrolidone Polymers 0.000 description 4
238000003825 pressing Methods 0.000 description 4
230000035812 respiration Effects 0.000 description 4
230000029058 respiratory gaseous exchange Effects 0.000 description 4
229910001923 silver oxide Inorganic materials 0.000 description 4
239000002904 solvent Substances 0.000 description 4
239000000600 sorbitol Substances 0.000 description 4
239000003549 soybean oil Substances 0.000 description 4
235000012424 soybean oil Nutrition 0.000 description 4
238000001356 surgical procedure Methods 0.000 description 4
230000001225 therapeutic Effects 0.000 description 4
230000036912 Bioavailability Effects 0.000 description 3
229910001339 C alloy Inorganic materials 0.000 description 3
MTHSVFCYNBDYFN-UHFFFAOYSA-N Diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 3
102000004190 Enzymes Human genes 0.000 description 3
108090000790 Enzymes Proteins 0.000 description 3
210000003405 Ileum Anatomy 0.000 description 3
210000001630 Jejunum Anatomy 0.000 description 3
210000004072 Lung Anatomy 0.000 description 3
210000000214 Mouth Anatomy 0.000 description 3
WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinylpyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 3
UIIMBOGNXHQVGW-UHFFFAOYSA-M NaHCO3 Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 3
239000004696 Poly ether ether ketone Substances 0.000 description 3
229920000604 Polyethylene Glycol 200 Polymers 0.000 description 3
239000004793 Polystyrene Substances 0.000 description 3
210000001187 Pylorus Anatomy 0.000 description 3
BLUAFEHZUWYNDE-OWBKAPBLSA-N Quing hau sau Natural products O=C1[C@H](C)[C@H]2[C@@]34OO[C@@](C)(O[C@H]3O1)CC[C@H]4[C@@H](C)CC2 BLUAFEHZUWYNDE-OWBKAPBLSA-N 0.000 description 3
QORWJWZARLRLPR-UHFFFAOYSA-H Tricalcium phosphate Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 3
MCMNRKCIXSYSNV-UHFFFAOYSA-N ZrO2 Chemical compound O=[Zr]=O MCMNRKCIXSYSNV-UHFFFAOYSA-N 0.000 description 3
238000010521 absorption reaction Methods 0.000 description 3
CSCPPACGZOOCGX-UHFFFAOYSA-N acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
PNEYBMLMFCGWSK-UHFFFAOYSA-N al2o3 Chemical compound [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 3
239000003963 antioxidant agent Substances 0.000 description 3
235000006708 antioxidants Nutrition 0.000 description 3
229960004191 artemisinin Drugs 0.000 description 3
230000035514 bioavailability Effects 0.000 description 3
239000000292 calcium oxide Substances 0.000 description 3
239000001506 calcium phosphate Substances 0.000 description 3
238000004364 calculation method Methods 0.000 description 3
239000000828 canola oil Substances 0.000 description 3
235000019519 canola oil Nutrition 0.000 description 3
CURLTUGMZLYLDI-UHFFFAOYSA-N carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 3
210000004027 cells Anatomy 0.000 description 3
VYZAMTAEIAYCRO-UHFFFAOYSA-N chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 3
229910052804 chromium Inorganic materials 0.000 description 3
239000011651 chromium Substances 0.000 description 3
239000003086 colorant Substances 0.000 description 3
RYGMFSIKBFXOCR-UHFFFAOYSA-N copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 3
239000010949 copper Substances 0.000 description 3
229910052802 copper Inorganic materials 0.000 description 3
238000005336 cracking Methods 0.000 description 3
238000003745 diagnosis Methods 0.000 description 3
BDAGIHXWWSANSR-UHFFFAOYSA-N formic acid Chemical compound OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 3
PEDCQBHIVMGVHV-UHFFFAOYSA-N glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
238000010438 heat treatment Methods 0.000 description 3
239000003018 immunosuppressive agent Substances 0.000 description 3
239000004615 ingredient Substances 0.000 description 3
230000002401 inhibitory effect Effects 0.000 description 3
238000002350 laparotomy Methods 0.000 description 3
230000002934 lysing Effects 0.000 description 3
235000019359 magnesium stearate Nutrition 0.000 description 3
238000002844 melting Methods 0.000 description 3
ZOKXTWBITQBERF-UHFFFAOYSA-N molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 3
239000011733 molybdenum Substances 0.000 description 3
229910052750 molybdenum Inorganic materials 0.000 description 3
239000008188 pellet Substances 0.000 description 3
229920003023 plastic Polymers 0.000 description 3
239000004033 plastic Substances 0.000 description 3
239000004014 plasticizer Substances 0.000 description 3
229920002530 poly[4-(4-benzoylphenoxy)phenol] polymer Polymers 0.000 description 3
229920001888 polyacrylic acid Polymers 0.000 description 3
229920000515 polycarbonate Polymers 0.000 description 3
239000004417 polycarbonate Substances 0.000 description 3
229920002223 polystyrene Polymers 0.000 description 3
239000001267 polyvinylpyrrolidone Substances 0.000 description 3
235000013855 polyvinylpyrrolidone Nutrition 0.000 description 3
102000004196 processed proteins & peptides Human genes 0.000 description 3
108090000765 processed proteins & peptides Proteins 0.000 description 3
230000000541 pulsatile Effects 0.000 description 3
230000002829 reduced Effects 0.000 description 3
238000002821 scintillation proximity assay Methods 0.000 description 3
239000000377 silicon dioxide Substances 0.000 description 3
235000012239 silicon dioxide Nutrition 0.000 description 3
238000004088 simulation Methods 0.000 description 3
HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
229910052719 titanium Inorganic materials 0.000 description 3
239000010936 titanium Substances 0.000 description 3
RTAQQCXQSZGOHL-UHFFFAOYSA-N titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 3
229940078499 tricalcium phosphate Drugs 0.000 description 3
229910000391 tricalcium phosphate Inorganic materials 0.000 description 3
235000019731 tricalcium phosphate Nutrition 0.000 description 3
WFKWXMTUELFFGS-UHFFFAOYSA-N tungsten Chemical compound [W] WFKWXMTUELFFGS-UHFFFAOYSA-N 0.000 description 3
239000010937 tungsten Substances 0.000 description 3
229910052721 tungsten Inorganic materials 0.000 description 3
241001515965 unidentified phage Species 0.000 description 3
229910001928 zirconium oxide Inorganic materials 0.000 description 3
SXYIRMFQILZOAM-HVNFFKDJSA-N (3R,5aS,6R,8aS,9R,10S,12R,12aR)-10-methoxy-3,6,9-trimethyldecahydro-3,12-epoxypyrano[4,3-j][1,2]benzodioxepines Chemical compound C1C[C@H]2[C@H](C)CC[C@H]3[C@@H](C)[C@@H](OC)O[C@H]4[C@]32OO[C@@]1(C)O4 SXYIRMFQILZOAM-HVNFFKDJSA-N 0.000 description 2
229920000160 (ribonucleotides)n+m Polymers 0.000 description 2
GXCDLJXPZVCHBX-UHFFFAOYSA-N 3-methylpent-1-yn-3-yl carbamate Chemical compound CCC(C)(C#C)OC(N)=O GXCDLJXPZVCHBX-UHFFFAOYSA-N 0.000 description 2
CWSZBVAUYPTXTG-UHFFFAOYSA-N 5-[6-[[3,4-dihydroxy-6-(hydroxymethyl)-5-methoxyoxan-2-yl]oxymethyl]-3,4-dihydroxy-5-[4-hydroxy-3-(2-hydroxyethoxy)-6-(hydroxymethyl)-5-methoxyoxan-2-yl]oxyoxan-2-yl]oxy-6-(hydroxymethyl)-2-methyloxane-3,4-diol Chemical compound O1C(CO)C(OC)C(O)C(O)C1OCC1C(OC2C(C(O)C(OC)C(CO)O2)OCCO)C(O)C(O)C(OC2C(OC(C)C(O)C2O)CO)O1 CWSZBVAUYPTXTG-UHFFFAOYSA-N 0.000 description 2
229940035676 ANALGESICS Drugs 0.000 description 2
229940005529 ANTIPSYCHOTICS Drugs 0.000 description 2
210000001015 Abdomen Anatomy 0.000 description 2
229940064005 Antibiotic throat preparations Drugs 0.000 description 2
229940083879 Antibiotics FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE Drugs 0.000 description 2
229940042052 Antibiotics for systemic use Drugs 0.000 description 2
229940042786 Antitubercular Antibiotics Drugs 0.000 description 2
FIHJKUPKCHIPAT-AXFKQHSWSA-N Artesunate Chemical compound C([C@@](OO1)(C)O2)C[C@H]3[C@H](C)CC[C@@H]4[C@@]31[C@@H]2O[C@@H](OC(=O)CCC(O)=O)[C@@H]4C FIHJKUPKCHIPAT-AXFKQHSWSA-N 0.000 description 2
230000035639 Blood Levels Effects 0.000 description 2
229960005069 Calcium Drugs 0.000 description 2
229920002301 Cellulose acetate Polymers 0.000 description 2
238000002965 ELISA Methods 0.000 description 2
210000000887 Face Anatomy 0.000 description 2
LNTHITQWFMADLM-UHFFFAOYSA-N Gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 2
210000001156 Gastric Mucosa Anatomy 0.000 description 2
229940093922 Gynecological Antibiotics Drugs 0.000 description 2
210000002216 Heart Anatomy 0.000 description 2
239000004354 Hydroxyethyl cellulose Substances 0.000 description 2
229920000663 Hydroxyethyl cellulose Polymers 0.000 description 2
229920002153 Hydroxypropyl cellulose Polymers 0.000 description 2
229960003444 IMMUNOSUPPRESSANTS Drugs 0.000 description 2
210000003734 Kidney Anatomy 0.000 description 2
ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 2
OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 2
210000004185 Liver Anatomy 0.000 description 2
108020004999 Messenger RNA Proteins 0.000 description 2
241000192041 Micrococcus Species 0.000 description 2
229940005483 OPIOID ANALGESICS Drugs 0.000 description 2
FELGMEQIXOGIFQ-UHFFFAOYSA-N Ondansetron Chemical compound CC1=NC=CN1CC1C(=O)C(C=2C(=CC=CC=2)N2C)=C2CC1 FELGMEQIXOGIFQ-UHFFFAOYSA-N 0.000 description 2
229960005343 Ondansetron Drugs 0.000 description 2
XAPRFLSJBSXESP-UHFFFAOYSA-N Oxycinchophen Chemical compound N=1C2=CC=CC=C2C(C(=O)O)=C(O)C=1C1=CC=CC=C1 XAPRFLSJBSXESP-UHFFFAOYSA-N 0.000 description 2
210000000496 Pancreas Anatomy 0.000 description 2
LOUPRKONTZGTKE-WZBLMQSHSA-N Quinine Chemical compound C([C@H]([C@H](C1)C=C)C2)C[N@@]1[C@@H]2[C@H](O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-WZBLMQSHSA-N 0.000 description 2
241000580858 Simian-Human immunodeficiency virus Species 0.000 description 2
210000000952 Spleen Anatomy 0.000 description 2
229920002472 Starch Polymers 0.000 description 2
QIQXTHQIDYTFRH-UHFFFAOYSA-N Stearic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 2
229940024982 Topical Antifungal Antibiotics Drugs 0.000 description 2
210000003932 Urinary Bladder Anatomy 0.000 description 2
229940029983 VITAMINS Drugs 0.000 description 2
229940021016 Vitamin IV solution additives Drugs 0.000 description 2
230000003187 abdominal Effects 0.000 description 2
WEVYAHXRMPXWCK-UHFFFAOYSA-N acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 2
NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 2
150000001298 alcohols Chemical class 0.000 description 2
229910052782 aluminium Inorganic materials 0.000 description 2
230000000202 analgesic Effects 0.000 description 2
238000010171 animal model Methods 0.000 description 2
239000000730 antalgic agent Substances 0.000 description 2
239000003242 anti bacterial agent Substances 0.000 description 2
230000001387 anti-histamine Effects 0.000 description 2
230000000111 anti-oxidant Effects 0.000 description 2
230000000561 anti-psychotic Effects 0.000 description 2
239000003146 anticoagulant agent Substances 0.000 description 2
239000000739 antihistaminic agent Substances 0.000 description 2
229960000070 antineoplastic Monoclonal antibodies Drugs 0.000 description 2
239000000164 antipsychotic agent Substances 0.000 description 2
229960000981 artemether Drugs 0.000 description 2
229960004991 artesunate Drugs 0.000 description 2
230000003115 biocidal Effects 0.000 description 2
230000033228 biological regulation Effects 0.000 description 2
230000037396 body weight Effects 0.000 description 2
RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
OYPRJOBELJOOCE-UHFFFAOYSA-N calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
239000011575 calcium Substances 0.000 description 2
229910052791 calcium Inorganic materials 0.000 description 2
235000001465 calcium Nutrition 0.000 description 2
VTYYLEPIZMXCLO-UHFFFAOYSA-L calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
239000001569 carbon dioxide Substances 0.000 description 2
229910002092 carbon dioxide Inorganic materials 0.000 description 2
229920002678 cellulose Polymers 0.000 description 2
239000001913 cellulose Substances 0.000 description 2
238000006243 chemical reaction Methods 0.000 description 2
HGAZMNJKRQFZKS-UHFFFAOYSA-N chloroethene;ethenyl acetate Chemical compound ClC=C.CC(=O)OC=C HGAZMNJKRQFZKS-UHFFFAOYSA-N 0.000 description 2
150000001875 compounds Chemical class 0.000 description 2
238000005520 cutting process Methods 0.000 description 2
230000009089 cytolysis Effects 0.000 description 2
230000002354 daily Effects 0.000 description 2
238000000354 decomposition reaction Methods 0.000 description 2
238000002716 delivery method Methods 0.000 description 2
235000005911 diet Nutrition 0.000 description 2
230000037213 diet Effects 0.000 description 2
230000029087 digestion Effects 0.000 description 2
239000000975 dye Substances 0.000 description 2
239000000806 elastomer Substances 0.000 description 2
230000002255 enzymatic Effects 0.000 description 2
238000001952 enzyme assay Methods 0.000 description 2
230000004438 eyesight Effects 0.000 description 2
239000010408 film Substances 0.000 description 2
OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
230000037406 food intake Effects 0.000 description 2
230000005021 gait Effects 0.000 description 2
238000003304 gavage Methods 0.000 description 2
150000004676 glycans Polymers 0.000 description 2
LYCAIKOWRPUZTN-UHFFFAOYSA-N glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
238000010562 histological examination Methods 0.000 description 2
239000000017 hydrogel Substances 0.000 description 2
235000019447 hydroxyethyl cellulose Nutrition 0.000 description 2
239000001863 hydroxypropyl cellulose Substances 0.000 description 2
235000010977 hydroxypropyl cellulose Nutrition 0.000 description 2
230000002218 hypoglycaemic Effects 0.000 description 2
230000001861 immunosuppresant Effects 0.000 description 2
238000011065 in-situ storage Methods 0.000 description 2
239000003112 inhibitor Substances 0.000 description 2
229940079866 intestinal antibiotics Drugs 0.000 description 2
229920002106 messenger RNA Polymers 0.000 description 2
229910001092 metal group alloy Inorganic materials 0.000 description 2
229920000609 methyl cellulose Polymers 0.000 description 2
239000001923 methylcellulose Substances 0.000 description 2
235000010981 methylcellulose Nutrition 0.000 description 2
238000003801 milling Methods 0.000 description 2
230000003278 mimic Effects 0.000 description 2
239000002480 mineral oil Substances 0.000 description 2
235000010446 mineral oil Nutrition 0.000 description 2
229960000060 monoclonal antibodies Drugs 0.000 description 2
230000003387 muscular Effects 0.000 description 2
239000000041 non-steroidal anti-inflammatory agent Substances 0.000 description 2
235000016709 nutrition Nutrition 0.000 description 2
230000035764 nutrition Effects 0.000 description 2
229940005935 ophthalmologic Antibiotics Drugs 0.000 description 2
230000003364 opioid Effects 0.000 description 2
239000003960 organic solvent Substances 0.000 description 2
230000036407 pain Effects 0.000 description 2
230000002572 peristaltic Effects 0.000 description 2
239000008194 pharmaceutical composition Substances 0.000 description 2
230000000144 pharmacologic effect Effects 0.000 description 2
ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
229920001282 polysaccharide Polymers 0.000 description 2
239000005017 polysaccharide Substances 0.000 description 2
150000004804 polysaccharides Polymers 0.000 description 2
238000005381 potential energy Methods 0.000 description 2
DNIAPMSPPWPWGF-UHFFFAOYSA-N propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 2
230000012846 protein folding Effects 0.000 description 2
238000011160 research Methods 0.000 description 2
230000002441 reversible Effects 0.000 description 2
238000005070 sampling Methods 0.000 description 2
150000004760 silicates Chemical class 0.000 description 2
FAPWRFPIFSIZLT-UHFFFAOYSA-M sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
239000008107 starch Substances 0.000 description 2
235000019698 starch Nutrition 0.000 description 2
239000000021 stimulant Substances 0.000 description 2
231100000212 subchronic toxicity study Toxicity 0.000 description 2
238000010254 subcutaneous injection Methods 0.000 description 2
239000007929 subcutaneous injection Substances 0.000 description 2
210000004876 tela submucosa Anatomy 0.000 description 2
GWEVSGVZZGPLCZ-UHFFFAOYSA-N titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
231100000820 toxicity test Toxicity 0.000 description 2
239000003981 vehicle Substances 0.000 description 2
235000013343 vitamin Nutrition 0.000 description 2
239000011782 vitamin Substances 0.000 description 2
229930003231 vitamins Natural products 0.000 description 2
LNAZSHAWQACDHT-XIYTZBAFSA-N (2R,3R,4S,5R,6S)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2S,3R,4S,5R,6R)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2R,3R,4S,5R,6R)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 1
BJDCWCLMFKKGEE-ISOSDAIHSA-N (3R,5aS,6R,8aS,9R,10S,12R,12aR)-Decahydro-3,6,9-trimethyl-3,12-epoxy-12H-pyrano[4,3-j]-1,2-benzodioxepin-10-ol Chemical compound C([C@](OO1)(C)O2)C[C@H]3[C@H](C)CC[C@@H]4[C@@]31[C@@H]2O[C@H](O)[C@@H]4C BJDCWCLMFKKGEE-ISOSDAIHSA-N 0.000 description 1
PMATZTZNYRCHOR-CGLBZJNRSA-N (3S,6S,9S,12R,15S,18S,21S,24S,30S,33S)-30-ethyl-33-[(E,1R,2R)-1-hydroxy-2-methylhex-4-enyl]-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-3,21-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17 Chemical compound CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O PMATZTZNYRCHOR-CGLBZJNRSA-N 0.000 description 1
DEQANNDTNATYII-OULOTJBUSA-N (4R,7S,10S,13R,16S,19R)-10-(4-aminobutyl)-19-[[(2R)-2-amino-3-phenylpropanoyl]amino]-16-benzyl-N-[(2R,3R)-1,3-dihydroxybutan-2-yl]-7-[(1R)-1-hydroxyethyl]-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxa Chemical compound C([C@@H](N)C(=O)N[C@H]1CSSC[C@H](NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](CC=2C3=CC=CC=C3NC=2)NC(=O)[C@H](CC=2C=CC=CC=2)NC1=O)C(=O)N[C@H](CO)[C@H](O)C)C1=CC=CC=C1 DEQANNDTNATYII-OULOTJBUSA-N 0.000 description 1
VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 description 1
NTINFTOOVNKGIU-UHFFFAOYSA-M 2-(2-hydroxyethoxycarbonyl)benzoate Chemical compound OCCOC(=O)C1=CC=CC=C1C([O-])=O NTINFTOOVNKGIU-UHFFFAOYSA-M 0.000 description 1
KUCQYCKVKVOKAY-CTYIDZIISA-N 2-hydroxy-3-[(1r,4r)-4-(4-chlorophenyl)cyclohexyl]-1,4-dihydronaphthalene-1,4-dione Chemical compound C1([C@H]2CC[C@@H](CC2)C2=C(C(C3=CC=CC=C3C2=O)=O)O)=CC=C(Cl)C=C1 KUCQYCKVKVOKAY-CTYIDZIISA-N 0.000 description 1
WHJKCPTVEYZNOG-UHFFFAOYSA-N 6-(hydroxymethyl)-5-methoxy-2-[4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane-3,4-diol Chemical group COCC1OC(OC)C(OC)C(OC)C1OC1C(O)C(O)C(OC)C(CO)O1 WHJKCPTVEYZNOG-UHFFFAOYSA-N 0.000 description 1
229930006677 A03BA01 - Atropine Natural products 0.000 description 1
229940100198 ALKYLATING AGENTS Drugs 0.000 description 1
229940035674 ANESTHETICS Drugs 0.000 description 1
229940005513 ANTIDEPRESSANTS Drugs 0.000 description 1
229940116904 ANTIINFLAMMATORY THERAPEUTIC RADIOPHARMACEUTICALS Drugs 0.000 description 1
229960004676 ANTITHROMBOTIC AGENTS Drugs 0.000 description 1
244000215068 Acacia senegal Species 0.000 description 1
229920000178 Acrylic resin Polymers 0.000 description 1
239000004925 Acrylic resin Substances 0.000 description 1
241000251468 Actinopterygii Species 0.000 description 1
229960001444 Amodiaquine Drugs 0.000 description 1
108020000948 Antisense Oligonucleotides Proteins 0.000 description 1
210000001367 Arteries Anatomy 0.000 description 1
RKUNBYITZUJHSG-SPUOUPEWSA-N Atropine Chemical compound O([C@H]1C[C@H]2CC[C@@H](C1)N2C)C(=O)C(CO)C1=CC=CC=C1 RKUNBYITZUJHSG-SPUOUPEWSA-N 0.000 description 1
229960000396 Atropine Drugs 0.000 description 1
241000271566 Aves Species 0.000 description 1
MQTOSJVFKKJCRP-BICOPXKESA-N Azithromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)N(C)C[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 MQTOSJVFKKJCRP-BICOPXKESA-N 0.000 description 1
239000005552 B01AC04 - Clopidogrel Substances 0.000 description 1
229960002747 Betacarotene Drugs 0.000 description 1
210000001124 Body Fluids Anatomy 0.000 description 1
229920000033 CRISPR Polymers 0.000 description 1
WCWSTNLSLKSJPK-LKFCYVNXSA-N Cabotegravir Chemical compound C([C@H]1OC[C@@H](N1C(=O)C1=C(O)C2=O)C)N1C=C2C(=O)NCC1=CC=C(F)C=C1F WCWSTNLSLKSJPK-LKFCYVNXSA-N 0.000 description 1
229950005928 Cabotegravir Drugs 0.000 description 1
229960003563 Calcium Carbonate Drugs 0.000 description 1
OVCDSSHSILBFBN-UHFFFAOYSA-N Camoquin Chemical compound C1=C(O)C(CN(CC)CC)=CC(NC=2C3=CC=C(Cl)C=C3N=CC=2)=C1 OVCDSSHSILBFBN-UHFFFAOYSA-N 0.000 description 1
241000282472 Canis lupus familiaris Species 0.000 description 1
241000283707 Capra Species 0.000 description 1
241000700198 Cavia Species 0.000 description 1
LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 description 1
BXWNKGSJHAJOGX-UHFFFAOYSA-N Cetyl alcohol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 1
229920001661 Chitosan Polymers 0.000 description 1
229960003677 Chloroquine Drugs 0.000 description 1
WHTVZRBIWZFKQO-UHFFFAOYSA-N Chloroquine Chemical compound ClC1=CC=C2C(NC(C)CCCN(CC)CC)=CC=NC2=C1 WHTVZRBIWZFKQO-UHFFFAOYSA-N 0.000 description 1
210000004913 Chyme Anatomy 0.000 description 1
235000001258 Cinchona calisaya Nutrition 0.000 description 1
241000434299 Cinchona officinalis Species 0.000 description 1
KDLRVYVGXIQJDK-AWPVFWJPSA-N Clindamycin Chemical compound CN1C[C@H](CCC)C[C@H]1C(=O)N[C@H]([C@H](C)Cl)[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](SC)O1 KDLRVYVGXIQJDK-AWPVFWJPSA-N 0.000 description 1
229960003009 Clopidogrel Drugs 0.000 description 1
GKTWGGQPFAXNFI-HNNXBMFYSA-N Clopidogrel Chemical compound C1([C@H](N2CC=3C=CSC=3CC2)C(=O)OC)=CC=CC=C1Cl GKTWGGQPFAXNFI-HNNXBMFYSA-N 0.000 description 1
RGJOEKWQDUBAIZ-IBOSZNHHSA-N CoASH Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCS)O[C@H]1N1C2=NC=NC(N)=C2N=C1 RGJOEKWQDUBAIZ-IBOSZNHHSA-N 0.000 description 1
JYGXADMDTFJGBT-VWUMJDOOSA-N Cortisol Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 1
241000699800 Cricetinae Species 0.000 description 1
229920001651 Cyanoacrylate Polymers 0.000 description 1
229940119017 Cyclosporine Drugs 0.000 description 1
108010036949 Cyclosporine Proteins 0.000 description 1
COLNVLDHVKWLRT-MRVPVSSYSA-N D-phenylalanine Chemical compound OC(=O)[C@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-MRVPVSSYSA-N 0.000 description 1
OUYCCCASQSFEME-UHFFFAOYSA-N DL-tyrosine Chemical compound OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
OIFBSDVPJOWBCH-UHFFFAOYSA-N Diethyl carbonate Chemical compound CCOC(=O)OCC OIFBSDVPJOWBCH-UHFFFAOYSA-N 0.000 description 1
FLKPEMZONWLCSK-UHFFFAOYSA-N Diethyl phthalate Chemical compound CCOC(=O)C1=CC=CC=C1C(=O)OCC FLKPEMZONWLCSK-UHFFFAOYSA-N 0.000 description 1
LTMHDMANZUZIPE-PUGKRICDSA-N Digoxin Chemical compound C1[C@H](O)[C@H](O)[C@@H](C)O[C@H]1O[C@@H]1[C@@H](C)O[C@@H](O[C@@H]2[C@H](O[C@@H](O[C@@H]3C[C@@H]4[C@]([C@@H]5[C@H]([C@]6(CC[C@@H]([C@@]6(C)[C@H](O)C5)C=5COC(=O)C=5)O)CC4)(C)CC3)C[C@@H]2O)C)C[C@@H]1O LTMHDMANZUZIPE-PUGKRICDSA-N 0.000 description 1
LTMHDMANZUZIPE-AMTYYWEZSA-N Digoxin Natural products O([C@H]1[C@H](C)O[C@H](O[C@@H]2C[C@@H]3[C@@](C)([C@@H]4[C@H]([C@]5(O)[C@](C)([C@H](O)C4)[C@H](C4=CC(=O)OC4)CC5)CC3)CC2)C[C@@H]1O)[C@H]1O[C@H](C)[C@@H](O[C@H]2O[C@@H](C)[C@H](O)[C@@H](O)C2)[C@@H](O)C1 LTMHDMANZUZIPE-AMTYYWEZSA-N 0.000 description 1
RHWKPHLQXYSBKR-BMIGLBTASA-N Dolutegravir Chemical compound C([C@@H]1OCC[C@H](N1C(=O)C1=C(O)C2=O)C)N1C=C2C(=O)NCC1=CC=C(F)C=C1F RHWKPHLQXYSBKR-BMIGLBTASA-N 0.000 description 1
229940052760 Dopamine agonists Drugs 0.000 description 1
QDGZDCVAUDNJFG-FXQIFTODSA-N Entecavir Chemical compound C1=2NC(N)=NC(=O)C=2N=CN1[C@H]1C[C@H](O)[C@@H](CO)C1=C QDGZDCVAUDNJFG-FXQIFTODSA-N 0.000 description 1
210000000981 Epithelium Anatomy 0.000 description 1
241000283086 Equidae Species 0.000 description 1
241000588724 Escherichia coli Species 0.000 description 1
SUBDBMMJDZJVOS-UHFFFAOYSA-N Esomeprazole Chemical compound N=1C2=CC(OC)=CC=C2NC=1S(=O)CC1=NC=C(C)C(OC)=C1C SUBDBMMJDZJVOS-UHFFFAOYSA-N 0.000 description 1
229960005309 Estradiol Drugs 0.000 description 1
239000001856 Ethyl cellulose Substances 0.000 description 1
ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
206010015548 Euthanasia Diseases 0.000 description 1
108010011459 Exenatide Proteins 0.000 description 1
HTQBXNHDCUEHJF-XWLPCZSASA-N Exendin-4 Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)NCC(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CO)C(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)[C@@H](C)O)C(C)C)C1=CC=CC=C1 HTQBXNHDCUEHJF-XWLPCZSASA-N 0.000 description 1
OLNTVTPDXPETLC-XPWALMASSA-N Ezetimibe Chemical compound N1([C@@H]([C@H](C1=O)CC[C@H](O)C=1C=CC(F)=CC=1)C=1C=CC(O)=CC=1)C1=CC=C(F)C=C1 OLNTVTPDXPETLC-XPWALMASSA-N 0.000 description 1
229960000301 Factor VIII Drugs 0.000 description 1
102000001690 Factor VIII Human genes 0.000 description 1
108010054218 Factor VIII Proteins 0.000 description 1
241000282326 Felis catus Species 0.000 description 1
LLQPHQFNMLZJMP-UHFFFAOYSA-N Fentrazamide Chemical compound N1=NN(C=2C(=CC=CC=2)Cl)C(=O)N1C(=O)N(CC)C1CCCCC1 LLQPHQFNMLZJMP-UHFFFAOYSA-N 0.000 description 1
240000006538 Ficus sycomorus Species 0.000 description 1
KKGQTZUTZRNORY-UHFFFAOYSA-N Fingolimod Chemical compound CCCCCCCCC1=CC=C(CCC(N)(CO)CO)C=C1 KKGQTZUTZRNORY-UHFFFAOYSA-N 0.000 description 1
229960000304 Folic Acid Drugs 0.000 description 1
101700069532 GSTF2 Proteins 0.000 description 1
229940074391 Gallic acid Drugs 0.000 description 1
241000287828 Gallus gallus Species 0.000 description 1
210000003736 Gastrointestinal Contents Anatomy 0.000 description 1
208000001288 Gastroparesis Diseases 0.000 description 1
229920002148 Gellan gum Polymers 0.000 description 1
COCFEDIXXNGUNL-RFKWWTKHSA-N Glargine Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H]1CSSC[C@H]2C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3C=CC(O)=CC=3)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3NC=NC=3)NC(=O)[C@H](CO)NC(=O)CNC1=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(=O)NCC(O)=O)=O)CSSC[C@@H](C(N2)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)CN)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC=1C=CC=CC=1)C(C)C)C1=CN=CN1 COCFEDIXXNGUNL-RFKWWTKHSA-N 0.000 description 1
108010072051 Glatiramer Acetate Proteins 0.000 description 1
229940065521 Glucocorticoid inhalants for obstructive airway disease Drugs 0.000 description 1
229940045189 Glucose-6-Phosphate Drugs 0.000 description 1
NBSCHQHZLSJFNQ-GASJEMHNSA-N Glucose-6-phosphate Chemical compound OC1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H](O)[C@H]1O NBSCHQHZLSJFNQ-GASJEMHNSA-N 0.000 description 1
102000003886 Glycoproteins Human genes 0.000 description 1
108090000288 Glycoproteins Proteins 0.000 description 1
102000018997 Growth Hormone Human genes 0.000 description 1
108010051696 Growth Hormone Proteins 0.000 description 1
229920000084 Gum arabic Polymers 0.000 description 1
229940093912 Gynecological Sulfonamides Drugs 0.000 description 1
206010018987 Haemorrhage Diseases 0.000 description 1
208000006454 Hepatitis Diseases 0.000 description 1
208000007514 Herpes Zoster Diseases 0.000 description 1
WNRQPCUGRUFHED-DETKDSODSA-N Humalog Chemical compound C([C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CS)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](CO)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CS)NC(=O)[C@H](CS)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)CN)[C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(O)=O)C1=CC=C(O)C=C1.C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(C)C)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC=1C=CC=CC=1)C(C)C)C1=CN=CN1 WNRQPCUGRUFHED-DETKDSODSA-N 0.000 description 1
208000006572 Human Influenza Diseases 0.000 description 1
102000000521 Immunophilins Human genes 0.000 description 1
108010016648 Immunophilins Proteins 0.000 description 1
206010021518 Impaired gastric emptying Diseases 0.000 description 1
206010061218 Inflammation Diseases 0.000 description 1
108010053490 Infliximab Proteins 0.000 description 1
206010022000 Influenza Diseases 0.000 description 1
108010073961 Insulin Aspart Proteins 0.000 description 1
108010089308 Insulin Detemir Proteins 0.000 description 1
108010057186 Insulin Glargine Proteins 0.000 description 1
229960002869 Insulin Glargine Drugs 0.000 description 1
108010065920 Insulin Lispro Proteins 0.000 description 1
229960002068 Insulin Lispro Drugs 0.000 description 1
102000014150 Interferons Human genes 0.000 description 1
108010050904 Interferons Proteins 0.000 description 1
229940047124 Interferons Drugs 0.000 description 1
229940046732 Interleukin inhibitors Drugs 0.000 description 1
102000010789 Interleukin-2 Receptors Human genes 0.000 description 1
108010038453 Interleukin-2 Receptors Proteins 0.000 description 1
210000000936 Intestines Anatomy 0.000 description 1
PIWKPBJCKXDKJR-UHFFFAOYSA-N Isoflurane Chemical compound FC(F)OC(Cl)C(F)(F)F PIWKPBJCKXDKJR-UHFFFAOYSA-N 0.000 description 1
229960005435 Ixekizumab Drugs 0.000 description 1
210000001847 Jaw Anatomy 0.000 description 1
235000014852 L-arginine Nutrition 0.000 description 1
COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
GUBGYTABKSRVRQ-UUNJERMWSA-N Lactose Natural products O([C@@H]1[C@H](O)[C@H](O)[C@H](O)O[C@@H]1CO)[C@H]1[C@@H](O)[C@@H](O)[C@H](O)[C@H](CO)O1 GUBGYTABKSRVRQ-UUNJERMWSA-N 0.000 description 1
UGOZVNFCFYTPAZ-IOXYNQHNSA-N Levemir Chemical compound CCCCCCCCCCCCCC(=O)NCCCC[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)CNC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@H]1NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=2C=CC(O)=CC=2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=2N=CNC=2)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=2N=CNC=2)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC=2C=CC=CC=2)C(C)C)CSSC[C@@H]2NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CN)[C@@H](C)CC)C(C)C)CSSC[C@H](NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](CO)NC(=O)[C@H]([C@@H](C)O)NC2=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N[C@@H](CSSC1)C(=O)N[C@@H](CC(N)=O)C(O)=O)CC1=CC=C(O)C=C1 UGOZVNFCFYTPAZ-IOXYNQHNSA-N 0.000 description 1
RDOIQAHITMMDAJ-UHFFFAOYSA-N Loperamide Chemical compound C=1C=CC=CC=1C(C=1C=CC=CC=1)(C(=O)N(C)C)CCN(CC1)CCC1(O)C1=CC=C(Cl)C=C1 RDOIQAHITMMDAJ-UHFFFAOYSA-N 0.000 description 1
229960001571 Loperamide Drugs 0.000 description 1
DYLGFOYVTXJFJP-MYYYXRDXSA-N Lumefantrine Chemical compound C12=CC(Cl)=CC=C2C=2C(C(O)CN(CCCC)CCCC)=CC(Cl)=CC=2\C1=C/C1=CC=C(Cl)C=C1 DYLGFOYVTXJFJP-MYYYXRDXSA-N 0.000 description 1
229940040129 Luteinizing Hormone Drugs 0.000 description 1
102000009151 Luteinizing Hormone Human genes 0.000 description 1
108010073521 Luteinizing Hormone Proteins 0.000 description 1
229940029985 MINERAL SUPPLEMENTS Drugs 0.000 description 1
229940035363 MUSCLE RELAXANTS Drugs 0.000 description 1
239000005913 Maltodextrin Substances 0.000 description 1
229920002774 Maltodextrin Polymers 0.000 description 1
241000124008 Mammalia Species 0.000 description 1
229960003987 Melatonin Drugs 0.000 description 1
210000004379 Membranes Anatomy 0.000 description 1
MWCLLHOVUTZFKS-UHFFFAOYSA-N Methyl 2-cyanoacrylate Chemical compound COC(=O)C(=C)C#N MWCLLHOVUTZFKS-UHFFFAOYSA-N 0.000 description 1
LXCFILQKKLGQFO-UHFFFAOYSA-N Methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 1
241000699670 Mus sp. Species 0.000 description 1
229940083876 Muscle relaxants FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE Drugs 0.000 description 1
210000000329 Myocytes, Smooth Muscle Anatomy 0.000 description 1
229940053207 Niacin Drugs 0.000 description 1
206010067482 No adverse event Diseases 0.000 description 1
VOMXSOIBEJBQNF-UTTRGDHVSA-N NovoRapid Chemical compound C([C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CS)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](CO)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CS)NC(=O)[C@H](CS)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)CN)[C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(O)=O)C1=CC=C(O)C=C1.C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(C)C)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC=1C=CC=CC=1)C(C)C)C1=CN=CN1 VOMXSOIBEJBQNF-UTTRGDHVSA-N 0.000 description 1
229940074726 OPHTHALMOLOGIC ANTIINFLAMMATORY AGENTS Drugs 0.000 description 1
208000008589 Obesity Diseases 0.000 description 1
108010016076 Octreotide Proteins 0.000 description 1
229960002700 Octreotide Drugs 0.000 description 1
229920000272 Oligonucleotide Polymers 0.000 description 1
206010058667 Oral toxicity Diseases 0.000 description 1
241000283898 Ovis Species 0.000 description 1
102000004316 Oxidoreductases Human genes 0.000 description 1
108090000854 Oxidoreductases Proteins 0.000 description 1
229940005542 PARASYMPATHOMIMETICS Drugs 0.000 description 1
CWRVKFFCRWGWCS-UHFFFAOYSA-N Pentrazole Chemical compound C1CCCCC2=NN=NN21 CWRVKFFCRWGWCS-UHFFFAOYSA-N 0.000 description 1
108090000284 Pepsin A Proteins 0.000 description 1
206010035664 Pneumonia Diseases 0.000 description 1
229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
229920002845 Poly(methacrylic acid) Polymers 0.000 description 1
229920001100 Polydextrose Polymers 0.000 description 1
108010005991 Pork Regular Insulin Proteins 0.000 description 1
XOFYZVNMUHMLCC-ZPOLXVRWSA-N Prednisone Chemical compound O=C1C=C[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 XOFYZVNMUHMLCC-ZPOLXVRWSA-N 0.000 description 1
INDBQLZJXZLFIT-UHFFFAOYSA-N Primaquine Chemical compound N1=CC=CC2=CC(OC)=CC(NC(C)CCCN)=C21 INDBQLZJXZLFIT-UHFFFAOYSA-N 0.000 description 1
229940082622 Prostaglandin cardiac therapy preparations Drugs 0.000 description 1
229940077717 Prostaglandin drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD) Drugs 0.000 description 1
229940077718 Proton pump inhibitors for peptic ulcer and GORD Drugs 0.000 description 1
210000004203 Pyloric Antrum Anatomy 0.000 description 1
229960000948 Quinine Drugs 0.000 description 1
238000003332 Raman imaging Methods 0.000 description 1
229960002477 Riboflavin Drugs 0.000 description 1
AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
AUNGANRZJHBGPY-OUCADQQQSA-N Riboflavin Natural products OC[C@@H](O)[C@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-OUCADQQQSA-N 0.000 description 1
229960001534 Risperidone Drugs 0.000 description 1
RAPZEAPATHNIPO-UHFFFAOYSA-N Risperidone Chemical compound FC1=CC=C2C(C3CCN(CC3)CCC=3C(=O)N4CCCCC4=NC=3C)=NOC2=C1 RAPZEAPATHNIPO-UHFFFAOYSA-N 0.000 description 1
108010001645 Rituximab Proteins 0.000 description 1
241000283984 Rodentia Species 0.000 description 1
206010039897 Sedation Diseases 0.000 description 1
229940053479 Selective serotonin reuptake inhibitors Drugs 0.000 description 1
DLSWIYLPEUIQAV-CCUURXOWSA-N Semaglutide Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCCNC(=O)COCCOCCNC(=O)COCCOCCNC(=O)CC[C@@H](NC(=O)CCCCCCCCCCCCCCCCC(O)=O)C(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)C(C)(C)NC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)[C@@H](C)O)C(C)C)C1=CC=CC=C1 DLSWIYLPEUIQAV-CCUURXOWSA-N 0.000 description 1
229950011186 Semaglutide Drugs 0.000 description 1
210000002356 Skeleton Anatomy 0.000 description 1
RYYKJJJTJZKILX-UHFFFAOYSA-M Sodium stearate Chemical compound [Na+].CCCCCCCCCCCCCCCCCC([O-])=O RYYKJJJTJZKILX-UHFFFAOYSA-M 0.000 description 1
229940105648 Soma Drugs 0.000 description 1
235000021355 Stearic acid Nutrition 0.000 description 1
241000869009 Stigmochelys Species 0.000 description 1
241000938811 Stigmochelys pardalis Species 0.000 description 1
229960004673 Sulfadoxine Drugs 0.000 description 1
VLYWMPOKSSWJAL-UHFFFAOYSA-N Sulfamethoxypyridazine Chemical compound N1=NC(OC)=CC=C1NS(=O)(=O)C1=CC=C(N)C=C1 VLYWMPOKSSWJAL-UHFFFAOYSA-N 0.000 description 1
229960004936 Sulfamethoxypyridazine Drugs 0.000 description 1
PJSFRIWCGOHTNF-UHFFFAOYSA-N Sulphormetoxin Chemical compound COC1=NC=NC(NS(=O)(=O)C=2C=CC(N)=CC=2)=C1OC PJSFRIWCGOHTNF-UHFFFAOYSA-N 0.000 description 1
229940037128 Systemic Glucocorticoids Drugs 0.000 description 1
108091008153 T cell receptors Proteins 0.000 description 1
102000016266 T-Cell Antigen Receptors Human genes 0.000 description 1
QJJXYPPXXYFBGM-LFZNUXCKSA-N Tacrolimus Chemical compound C1C[C@@H](O)[C@H](OC)C[C@@H]1\C=C(/C)[C@@H]1[C@H](C)[C@@H](O)CC(=O)[C@H](CC=C)/C=C(C)/C[C@H](C)C[C@H](OC)[C@H]([C@H](C[C@H]2C)OC)O[C@@]2(O)C(=O)C(=O)N2CCCC[C@H]2C(=O)O1 QJJXYPPXXYFBGM-LFZNUXCKSA-N 0.000 description 1
229960001967 Tacrolimus Drugs 0.000 description 1
229960003604 Testosterone Drugs 0.000 description 1
206010043376 Tetanus Diseases 0.000 description 1
JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
210000001685 Thyroid Gland Anatomy 0.000 description 1
102000011923 Thyrotropin Human genes 0.000 description 1
108010061174 Thyrotropin Proteins 0.000 description 1
229940060693 Tiletamine / Zolazepam Drugs 0.000 description 1
229960001295 Tocopherol Drugs 0.000 description 1
URAYPUMNDPQOKB-UHFFFAOYSA-N Triacetin Chemical compound CC(=O)OCC(OC(C)=O)COC(C)=O URAYPUMNDPQOKB-UHFFFAOYSA-N 0.000 description 1
229960002622 Triacetin Drugs 0.000 description 1
DOOTYTYQINUNNV-UHFFFAOYSA-N Triethyl citrate Chemical compound CCOC(=O)CC(O)(C(=O)OCC)CC(=O)OCC DOOTYTYQINUNNV-UHFFFAOYSA-N 0.000 description 1
210000002700 Urine Anatomy 0.000 description 1
210000003462 Veins Anatomy 0.000 description 1
229930003268 Vitamin C Natural products 0.000 description 1
229940046008 Vitamin D Drugs 0.000 description 1
229930003316 Vitamin D Natural products 0.000 description 1
BPICBUSOMSTKRF-UHFFFAOYSA-N Xylazine Chemical compound CC1=CC=CC(C)=C1NC1=NCCCS1 BPICBUSOMSTKRF-UHFFFAOYSA-N 0.000 description 1
229960001600 Xylazine Drugs 0.000 description 1
229940046282 Zinc Drugs 0.000 description 1
229940091251 Zinc Supplements Drugs 0.000 description 1
235000010489 acacia gum Nutrition 0.000 description 1
239000000205 acacia gum Substances 0.000 description 1
QTBSBXVTEAMEQO-UHFFFAOYSA-M acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
150000001242 acetic acid derivatives Chemical class 0.000 description 1
FHEAIOHRHQGZPC-KIWGSFCNSA-N acetic acid;(2S)-2-amino-3-(4-hydroxyphenyl)propanoic acid;(2S)-2-aminopentanedioic acid;(2S)-2-aminopropanoic acid;(2S)-2,6-diaminohexanoic acid Chemical compound CC(O)=O.C[C@H](N)C(O)=O.NCCCC[C@H](N)C(O)=O.OC(=O)[C@@H](N)CCC(O)=O.OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 FHEAIOHRHQGZPC-KIWGSFCNSA-N 0.000 description 1
DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
230000002378 acidificating Effects 0.000 description 1
150000007513 acids Chemical class 0.000 description 1
230000001154 acute Effects 0.000 description 1
231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
238000007792 addition Methods 0.000 description 1
230000001464 adherent Effects 0.000 description 1
UCTWMZQNUQWSLP-UHFFFAOYSA-N adrenaline Chemical compound CNCC(O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-UHFFFAOYSA-N 0.000 description 1
230000002411 adverse Effects 0.000 description 1
238000004378 air conditioning Methods 0.000 description 1
239000002168 alkylating agent Substances 0.000 description 1
229910045601 alloy Inorganic materials 0.000 description 1
239000000956 alloy Substances 0.000 description 1
239000002160 alpha blocker Substances 0.000 description 1
REDXJYDRNCIFBQ-UHFFFAOYSA-N aluminium(3+) Chemical class [Al+3] REDXJYDRNCIFBQ-UHFFFAOYSA-N 0.000 description 1
XAGFODPZIPBFFR-UHFFFAOYSA-N aluminum Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
150000001408 amides Chemical class 0.000 description 1
235000001014 amino acid Nutrition 0.000 description 1
150000001413 amino acids Chemical class 0.000 description 1
230000003444 anaesthetic Effects 0.000 description 1
238000004873 anchoring Methods 0.000 description 1
230000003042 antagnostic Effects 0.000 description 1
239000005557 antagonist Substances 0.000 description 1
230000001088 anti-asthma Effects 0.000 description 1
230000002429 anti-coagulation Effects 0.000 description 1
230000001430 anti-depressive Effects 0.000 description 1
230000000843 anti-fungal Effects 0.000 description 1
239000002260 anti-inflammatory agent Substances 0.000 description 1
230000000845 anti-microbial Effects 0.000 description 1
230000001028 anti-proliferant Effects 0.000 description 1
239000000924 antiasthmatic agent Substances 0.000 description 1
239000001961 anticonvulsive agent Substances 0.000 description 1
239000000935 antidepressant agent Substances 0.000 description 1
229940006131 antiglaucoma preparations and miotics Parasympathomimetics Drugs 0.000 description 1
239000004599 antimicrobial Substances 0.000 description 1
239000002246 antineoplastic agent Substances 0.000 description 1
230000003078 antioxidant Effects 0.000 description 1
239000003096 antiparasitic agent Substances 0.000 description 1
239000002221 antipyretic Substances 0.000 description 1
239000000074 antisense oligonucleotide Substances 0.000 description 1
239000003443 antiviral agent Substances 0.000 description 1
239000002249 anxiolytic agent Substances 0.000 description 1
239000003125 aqueous solvent Substances 0.000 description 1
KBZOIRJILGZLEJ-LGYYRGKSSA-N argipressin Chemical compound C([C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSC[C@@H](C(N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N1)=O)N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)C1=CC=CC=C1 KBZOIRJILGZLEJ-LGYYRGKSSA-N 0.000 description 1
229960002521 artenimol Drugs 0.000 description 1
238000003149 assay kit Methods 0.000 description 1
238000000418 atomic force spectrum Methods 0.000 description 1
238000000889 atomisation Methods 0.000 description 1
229960003159 atovaquone Drugs 0.000 description 1
229960004099 azithromycin Drugs 0.000 description 1
230000003385 bacteriostatic Effects 0.000 description 1
235000013871 bee wax Nutrition 0.000 description 1
239000012166 beeswax Substances 0.000 description 1
229940092738 beeswax Drugs 0.000 description 1
238000005452 bending Methods 0.000 description 1
OENHQHLEOONYIE-VYAWBVGESA-N beta-Carotene Natural products CC=1CCCC(C)(C)C=1\C=C\C(\C)=C/C=C/C(/C)=C\C=C\C=C(\C)/C=C/C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-VYAWBVGESA-N 0.000 description 1
239000011648 beta-carotene Substances 0.000 description 1
235000013734 beta-carotene Nutrition 0.000 description 1
230000000975 bioactive Effects 0.000 description 1
229920002988 biodegradable polymer Polymers 0.000 description 1
239000004621 biodegradable polymer Substances 0.000 description 1
229920001222 biopolymer Polymers 0.000 description 1
YBJHBAHKTGYVGT-ZKWXMUAHSA-N biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 1
239000011616 biotin Substances 0.000 description 1
229960002685 biotin Drugs 0.000 description 1
235000020958 biotin Nutrition 0.000 description 1
230000000740 bleeding Effects 0.000 description 1
231100000319 bleeding Toxicity 0.000 description 1
230000000903 blocking Effects 0.000 description 1
239000010839 body fluid Substances 0.000 description 1
230000037237 body shape Effects 0.000 description 1
229960001948 caffeine Drugs 0.000 description 1
229910000019 calcium carbonate Inorganic materials 0.000 description 1
235000010216 calcium carbonate Nutrition 0.000 description 1
150000001720 carbohydrates Chemical class 0.000 description 1
235000014633 carbohydrates Nutrition 0.000 description 1
235000011089 carbon dioxide Nutrition 0.000 description 1
239000001768 carboxy methyl cellulose Substances 0.000 description 1
239000002327 cardiovascular agent Substances 0.000 description 1
235000012730 carminic acid Nutrition 0.000 description 1
239000004203 carnauba wax Substances 0.000 description 1
235000013869 carnauba wax Nutrition 0.000 description 1
229940082483 carnauba wax Drugs 0.000 description 1
101700056051 cas9 Proteins 0.000 description 1
239000004359 castor oil Substances 0.000 description 1
235000019438 castor oil Nutrition 0.000 description 1
230000024881 catalytic activity Effects 0.000 description 1
238000006555 catalytic reaction Methods 0.000 description 1
239000006285 cell suspension Substances 0.000 description 1
238000005119 centrifugation Methods 0.000 description 1
229940082500 cetostearyl alcohol Drugs 0.000 description 1
229960000541 cetyl alcohol Drugs 0.000 description 1
238000005313 chemometric Methods 0.000 description 1
230000001055 chewing Effects 0.000 description 1
230000001906 cholesterol absorption Effects 0.000 description 1
229960001265 ciclosporin Drugs 0.000 description 1
239000004927 clay Substances 0.000 description 1
229910052570 clay Inorganic materials 0.000 description 1
229960002227 clindamycin Drugs 0.000 description 1
229920001940 conductive polymer Polymers 0.000 description 1
238000004624 confocal microscopy Methods 0.000 description 1
239000003433 contraceptive agent Substances 0.000 description 1
229920001577 copolymer Polymers 0.000 description 1
230000000875 corresponding Effects 0.000 description 1
231100000078 corrosive Toxicity 0.000 description 1
231100001010 corrosive Toxicity 0.000 description 1
238000010192 crystallographic characterization Methods 0.000 description 1
230000001472 cytotoxic Effects 0.000 description 1
231100000433 cytotoxic Toxicity 0.000 description 1
235000013365 dairy product Nutrition 0.000 description 1
230000013872 defecation Effects 0.000 description 1
238000007872 degassing Methods 0.000 description 1
230000003111 delayed Effects 0.000 description 1
239000000412 dendrimer Substances 0.000 description 1
229920000736 dendritic polymer Polymers 0.000 description 1
230000001419 dependent Effects 0.000 description 1
238000000151 deposition Methods 0.000 description 1
230000001687 destabilization Effects 0.000 description 1
230000000368 destabilizing Effects 0.000 description 1
238000001514 detection method Methods 0.000 description 1
238000011161 development Methods 0.000 description 1
230000018109 developmental process Effects 0.000 description 1
239000000032 diagnostic agent Substances 0.000 description 1
229960005156 digoxin Drugs 0.000 description 1
229930016266 dihydroartemisinin Natural products 0.000 description 1
238000010790 dilution Methods 0.000 description 1
238000007598 dipping method Methods 0.000 description 1
238000007922 dissolution test Methods 0.000 description 1
229960002542 dolutegravir Drugs 0.000 description 1
239000000386 donor Substances 0.000 description 1
239000003136 dopamine receptor stimulating agent Substances 0.000 description 1
KCXVZYZYPLLWCC-UHFFFAOYSA-N edta Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
235000013601 eggs Nutrition 0.000 description 1
150000002066 eicosanoids Chemical class 0.000 description 1
239000003792 electrolyte Substances 0.000 description 1
238000010828 elution Methods 0.000 description 1
238000001839 endoscopy Methods 0.000 description 1
238000005516 engineering process Methods 0.000 description 1
239000003623 enhancer Substances 0.000 description 1
230000002708 enhancing Effects 0.000 description 1
229960000980 entecavir Drugs 0.000 description 1
239000002532 enzyme inhibitor Substances 0.000 description 1
239000000262 estrogen Substances 0.000 description 1
LUJQXGBDWAGQHS-UHFFFAOYSA-N ethenyl acetate;phthalic acid Chemical compound CC(=O)OC=C.OC(=O)C1=CC=CC=C1C(O)=O LUJQXGBDWAGQHS-UHFFFAOYSA-N 0.000 description 1
229920001249 ethyl cellulose Polymers 0.000 description 1
235000019325 ethyl cellulose Nutrition 0.000 description 1
KQTVWCSONPJJPE-UHFFFAOYSA-N etridiazole Chemical compound CCOC1=NC(C(Cl)(Cl)Cl)=NS1 KQTVWCSONPJJPE-UHFFFAOYSA-N 0.000 description 1
230000003203 everyday Effects 0.000 description 1
229960001519 exenatide Drugs 0.000 description 1
229960000815 ezetimibe Drugs 0.000 description 1
239000000789 fastener Substances 0.000 description 1
235000020828 fasting Nutrition 0.000 description 1
239000007888 film coating Substances 0.000 description 1
238000009501 film coating Methods 0.000 description 1
229960000556 fingolimod Drugs 0.000 description 1
235000019152 folic acid Nutrition 0.000 description 1
239000011724 folic acid Substances 0.000 description 1
230000003325 follicular Effects 0.000 description 1
235000012631 food intake Nutrition 0.000 description 1
235000019253 formic acid Nutrition 0.000 description 1
239000012458 free base Substances 0.000 description 1
238000007710 freezing Methods 0.000 description 1
235000004515 gallic acid Nutrition 0.000 description 1
239000004083 gastrointestinal agent Substances 0.000 description 1
239000003193 general anesthetic agent Substances 0.000 description 1
229960003776 glatiramer acetate Drugs 0.000 description 1
239000003877 glucagon like peptide 1 receptor agonist Substances 0.000 description 1
239000003862 glucocorticoid Substances 0.000 description 1
239000003292 glue Substances 0.000 description 1
125000005456 glyceride group Chemical group 0.000 description 1
239000001087 glyceryl triacetate Substances 0.000 description 1
235000013773 glyceryl triacetate Nutrition 0.000 description 1
108010086781 golimumab Proteins 0.000 description 1
229960001743 golimumab Drugs 0.000 description 1
230000012010 growth Effects 0.000 description 1
239000000122 growth hormone Substances 0.000 description 1
239000003966 growth inhibitor Substances 0.000 description 1
230000036541 health Effects 0.000 description 1
231100000283 hepatitis Toxicity 0.000 description 1
229920002674 hyaluronan Polymers 0.000 description 1
229960003160 hyaluronic acid Drugs 0.000 description 1
229960000890 hydrocortisone Drugs 0.000 description 1
239000002471 hydroxymethylglutaryl coenzyme A reductase inhibitor Substances 0.000 description 1
230000000147 hypnotic Effects 0.000 description 1
239000003326 hypnotic agent Substances 0.000 description 1
229960003943 hypromellose Drugs 0.000 description 1
238000010191 image analysis Methods 0.000 description 1
238000007654 immersion Methods 0.000 description 1
230000001900 immune effect Effects 0.000 description 1
239000007943 implant Substances 0.000 description 1
230000004054 inflammatory process Effects 0.000 description 1
229960000598 infliximab Drugs 0.000 description 1
239000001023 inorganic pigment Substances 0.000 description 1
238000009413 insulation Methods 0.000 description 1
229960004717 insulin aspart Drugs 0.000 description 1
229960003948 insulin detemir Drugs 0.000 description 1
230000003914 insulin secretion Effects 0.000 description 1
229940079867 intestinal antiinfectives Sulfonamides Drugs 0.000 description 1
238000010255 intramuscular injection Methods 0.000 description 1
239000007927 intramuscular injection Substances 0.000 description 1
238000009114 investigational therapy Methods 0.000 description 1
229910052740 iodine Inorganic materials 0.000 description 1
239000011630 iodine Substances 0.000 description 1
PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
229960002358 iodine Drugs 0.000 description 1
235000013675 iodine Nutrition 0.000 description 1
UQSXHKLRYXJYBZ-UHFFFAOYSA-N iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 1
229910000460 iron oxide Inorganic materials 0.000 description 1
230000001788 irregular Effects 0.000 description 1
230000002427 irreversible Effects 0.000 description 1
FGKJLKRYENPLQH-UHFFFAOYSA-M isocaproate Chemical compound CC(C)CCC([O-])=O FGKJLKRYENPLQH-UHFFFAOYSA-M 0.000 description 1
229960002725 isoflurane Drugs 0.000 description 1
108010063443 ixekizumab Proteins 0.000 description 1
JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 1
239000008101 lactose Substances 0.000 description 1
GUBGYTABKSRVRQ-XLOQQCSPSA-N lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
230000004301 light adaptation Effects 0.000 description 1
235000020888 liquid diet Nutrition 0.000 description 1
229960004985 lumefantrine Drugs 0.000 description 1
239000006166 lysate Substances 0.000 description 1
239000011777 magnesium Substances 0.000 description 1
229910052749 magnesium Inorganic materials 0.000 description 1
230000005389 magnetism Effects 0.000 description 1
229940035034 maltodextrin Drugs 0.000 description 1
230000018984 mastication Effects 0.000 description 1
DRLFMBDRBRZALE-UHFFFAOYSA-N melatonin Chemical compound COC1=CC=C2NC=C(CCNC(C)=O)C2=C1 DRLFMBDRBRZALE-UHFFFAOYSA-N 0.000 description 1
239000000155 melt Substances 0.000 description 1
239000012528 membrane Substances 0.000 description 1
239000002207 metabolite Substances 0.000 description 1
150000002734 metacrylic acid derivatives Chemical class 0.000 description 1
GIYXAJPCNFJEHY-UHFFFAOYSA-N methyl-[3-phenyl-3-[4-(trifluoromethyl)phenoxy]propyl]azanium;chloride Chemical compound Cl.C=1C=CC=CC=1C(CCNC)OC1=CC=C(C(F)(F)F)C=C1 GIYXAJPCNFJEHY-UHFFFAOYSA-N 0.000 description 1
244000005700 microbiome Species 0.000 description 1
235000020786 mineral supplement Nutrition 0.000 description 1
239000000178 monomer Substances 0.000 description 1
101710031899 moon Proteins 0.000 description 1
230000004899 motility Effects 0.000 description 1
230000004690 mucosal barrier Effects 0.000 description 1
230000004118 muscle contraction Effects 0.000 description 1
239000003158 myorelaxant agent Substances 0.000 description 1
IMNFDUFMRHMDMM-UHFFFAOYSA-N n-heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 1
239000002105 nanoparticle Substances 0.000 description 1
201000003631 narcolepsy Diseases 0.000 description 1
239000004090 neuroprotective agent Substances 0.000 description 1
DFPAKSUCGFBDDF-UHFFFAOYSA-N nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 1
235000001968 nicotinic acid Nutrition 0.000 description 1
229960003512 nicotinic acid Drugs 0.000 description 1
239000011664 nicotinic acid Substances 0.000 description 1
235000015097 nutrients Nutrition 0.000 description 1
235000020824 obesity Nutrition 0.000 description 1
229960000381 omeprazole Drugs 0.000 description 1
229940005938 ophthalmologic antiinfectives Sulfonamides Drugs 0.000 description 1
230000003287 optical Effects 0.000 description 1
231100000418 oral toxicity Toxicity 0.000 description 1
210000000056 organs Anatomy 0.000 description 1
239000001301 oxygen Substances 0.000 description 1
MYMOFIZGZYHOMD-UHFFFAOYSA-N oxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
229910052760 oxygen Inorganic materials 0.000 description 1
229940094443 oxytocics Prostaglandins Drugs 0.000 description 1
239000012188 paraffin wax Substances 0.000 description 1
230000001499 parasympathomimetic Effects 0.000 description 1
239000000734 parasympathomimetic agent Substances 0.000 description 1
238000005192 partition Methods 0.000 description 1
230000000149 penetrating Effects 0.000 description 1
229940111202 pepsin Drugs 0.000 description 1
230000002688 persistence Effects 0.000 description 1
230000002085 persistent Effects 0.000 description 1
230000000275 pharmacokinetic Effects 0.000 description 1
125000005498 phthalate group Chemical class 0.000 description 1
230000001766 physiological effect Effects 0.000 description 1
239000000049 pigment Substances 0.000 description 1
239000000419 plant extract Substances 0.000 description 1
239000003375 plant hormone Substances 0.000 description 1
229910052697 platinum Inorganic materials 0.000 description 1
229920000058 polyacrylate Polymers 0.000 description 1
239000004584 polyacrylic acid Substances 0.000 description 1
239000001259 polydextrose Substances 0.000 description 1
235000013856 polydextrose Nutrition 0.000 description 1
229940035035 polydextrose Drugs 0.000 description 1
229920001296 polysiloxane Polymers 0.000 description 1
229920002689 polyvinyl acetate Polymers 0.000 description 1
239000011118 polyvinyl acetate Substances 0.000 description 1
229920000915 polyvinyl chloride Polymers 0.000 description 1
239000008057 potassium phosphate buffer Substances 0.000 description 1
230000002335 preservative Effects 0.000 description 1
239000003755 preservative agent Substances 0.000 description 1
230000002265 prevention Effects 0.000 description 1
229960005179 primaquine Drugs 0.000 description 1
238000000513 principal component analysis Methods 0.000 description 1
239000000583 progesterone congener Substances 0.000 description 1
230000002035 prolonged Effects 0.000 description 1
150000003180 prostaglandins Chemical class 0.000 description 1
230000003482 proton pump inhibitor Effects 0.000 description 1
239000000612 proton pump inhibitor Substances 0.000 description 1
238000011002 quantification Methods 0.000 description 1
238000002601 radiography Methods 0.000 description 1
238000001525 receptor binding assay Methods 0.000 description 1
108020003175 receptors Proteins 0.000 description 1
102000005962 receptors Human genes 0.000 description 1
239000003638 reducing agent Substances 0.000 description 1
239000003488 releasing hormone Substances 0.000 description 1
230000000268 renotropic Effects 0.000 description 1
210000002345 respiratory system Anatomy 0.000 description 1
230000000717 retained Effects 0.000 description 1
239000002151 riboflavin Substances 0.000 description 1
235000019192 riboflavin Nutrition 0.000 description 1
229960004641 rituximab Drugs 0.000 description 1
230000036280 sedation Effects 0.000 description 1
108010060325 semaglutide Proteins 0.000 description 1
239000003772 serotonin uptake inhibitor Substances 0.000 description 1
238000007873 sieving Methods 0.000 description 1
BPQQTUXANYXVAA-UHFFFAOYSA-N silicate Chemical compound [O-][Si]([O-])([O-])[O-] BPQQTUXANYXVAA-UHFFFAOYSA-N 0.000 description 1
239000004332 silver Substances 0.000 description 1
229910052709 silver Inorganic materials 0.000 description 1
BQCADISMDOOEFD-UHFFFAOYSA-N silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
235000017557 sodium bicarbonate Nutrition 0.000 description 1
229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
239000011780 sodium chloride Substances 0.000 description 1
235000002639 sodium chloride Nutrition 0.000 description 1
229940045902 sodium stearyl fumarate Drugs 0.000 description 1
MAKUBRYLFHZREJ-JWBQXVCJSA-M sodium;(2S,3S,4R,5R,6R)-3-[(2S,3R,5S,6R)-3-acetamido-5-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4,5,6-trihydroxyoxane-2-carboxylate Chemical compound [Na+].CC(=O)N[C@@H]1C[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](C([O-])=O)O[C@@H](O)[C@H](O)[C@H]1O MAKUBRYLFHZREJ-JWBQXVCJSA-M 0.000 description 1
STFSJTPVIIDAQX-LTRPLHCISA-M sodium;(E)-4-octadecoxy-4-oxobut-2-enoate Chemical compound [Na+].CCCCCCCCCCCCCCCCCCOC(=O)\C=C\C([O-])=O STFSJTPVIIDAQX-LTRPLHCISA-M 0.000 description 1
210000004872 soft tissue Anatomy 0.000 description 1
238000001228 spectrum Methods 0.000 description 1
239000007921 spray Substances 0.000 description 1
230000000087 stabilizing Effects 0.000 description 1
QIQXTHQIDYTFRH-UHFFFAOYSA-M stearate Chemical compound CCCCCCCCCCCCCCCCCC([O-])=O QIQXTHQIDYTFRH-UHFFFAOYSA-M 0.000 description 1
239000008117 stearic acid Substances 0.000 description 1
230000001429 stepping Effects 0.000 description 1
239000002294 steroidal antiinflammatory agent Substances 0.000 description 1
201000009032 substance abuse Diseases 0.000 description 1
231100000736 substance abuse Toxicity 0.000 description 1
150000003456 sulfonamides Chemical class 0.000 description 1
230000001502 supplementation Effects 0.000 description 1
230000002522 swelling Effects 0.000 description 1
239000000454 talc Substances 0.000 description 1
229910052623 talc Inorganic materials 0.000 description 1
239000008399 tap water Substances 0.000 description 1
235000020679 tap water Nutrition 0.000 description 1
230000002123 temporal effect Effects 0.000 description 1
238000002560 therapeutic procedure Methods 0.000 description 1
230000004797 therapeutic response Effects 0.000 description 1
235000019157 thiamine Nutrition 0.000 description 1
229960003495 thiamine Drugs 0.000 description 1
KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 1
239000011721 thiamine Substances 0.000 description 1
239000010409 thin film Substances 0.000 description 1
239000004408 titanium dioxide Substances 0.000 description 1
235000010384 tocopherol Nutrition 0.000 description 1
239000011732 tocopherol Substances 0.000 description 1
229930003799 tocopherols Natural products 0.000 description 1
235000015149 toffees Nutrition 0.000 description 1
238000003325 tomography Methods 0.000 description 1
229940026752 topical Sulfonamides Drugs 0.000 description 1
231100000419 toxicity Toxicity 0.000 description 1
230000001988 toxicity Effects 0.000 description 1
WEAPVABOECTMGR-UHFFFAOYSA-N triethyl 2-acetyloxypropane-1,2,3-tricarboxylate Chemical compound CCOC(=O)CC(C(=O)OCC)(OC(C)=O)CC(=O)OCC WEAPVABOECTMGR-UHFFFAOYSA-N 0.000 description 1
239000001069 triethyl citrate Substances 0.000 description 1
235000013769 triethyl citrate Nutrition 0.000 description 1
230000001960 triggered Effects 0.000 description 1
239000002452 tumor necrosis factor alpha inhibitor Substances 0.000 description 1
230000002485 urinary Effects 0.000 description 1
229960003726 vasopressin Drugs 0.000 description 1
235000013311 vegetables Nutrition 0.000 description 1
239000000052 vinegar Substances 0.000 description 1
125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
230000003612 virological Effects 0.000 description 1
235000019154 vitamin C Nutrition 0.000 description 1
239000011718 vitamin C Substances 0.000 description 1
150000003700 vitamin C derivatives Chemical class 0.000 description 1
235000019166 vitamin D Nutrition 0.000 description 1
239000011710 vitamin D Substances 0.000 description 1
150000003710 vitamin D derivatives Chemical class 0.000 description 1
235000019195 vitamin supplement Nutrition 0.000 description 1
239000003643 water by type Substances 0.000 description 1
238000009736 wetting Methods 0.000 description 1
229920001285 xanthan gum Polymers 0.000 description 1
239000000230 xanthan gum Substances 0.000 description 1
235000010493 xanthan gum Nutrition 0.000 description 1
229940082509 xanthan gum Drugs 0.000 description 1
GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1

JP2019563359A 2017-05-17 2018-05-17 組織繋留物品 Active JP7044805B2 (ja)